FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2608481654> ?p ?o ?g. }

• W2608481654 endingPage "97" @default.
• W2608481654 startingPage "85" @default.
• W2608481654 abstract "LX2761 is a potent sodium/glucose cotransporter 1 inhibitor restricted to the intestinal lumen after oral administration. Studies presented here evaluated the effect of orally administered LX2761 on glycemic control in preclinical models. In healthy mice and rats treated with LX2761, blood glucose excursions were lower and plasma total glucagon-like peptide-1 (GLP-1) levels higher after an oral glucose challenge; these decreased glucose excursions persisted even when the glucose challenge occurred 15 hours after LX2761 dosing in ad lib-fed mice. Further, treating mice with LX2761 and the dipeptidyl-peptidase 4 inhibitor sitagliptin synergistically increased active GLP-1 levels, suggesting increased LX2761-mediated release of GLP-1 into the portal circulation. LX2761 also lowered postprandial glucose, fasting glucose, and hemoglobin A1C, and increased plasma total GLP-1, during long-term treatment of mice with either early- or late-onset streptozotocin-diabetes; in the late-onset cohort, LX2761 treatment improved survival. Mice and rats treated with LX2761 occasionally had diarrhea; this dose-dependent side effect decreased in severity and frequency over time, and LX2761 doses were identified that decreased postprandial glucose excursions without causing diarrhea. Further, the frequency of LX2761-associated diarrhea was greatly decreased in mice either by gradual dose escalation or by pretreatment with resistant starch 4, which is slowly digested to glucose in the colon, a process that primes the colon for glucose metabolism by selecting for glucose-fermenting bacterial species. These data suggest that clinical trials are warranted to determine if LX2761 doses and dosing strategies exist that provide improved glycemic control combined with adequate gastrointestinal tolerability in people living with diabetes." @default.
• W2608481654 created "2017-05-05" @default.
• W2608481654 creator A5006130632 @default.
• W2608481654 creator A5006568353 @default.
• W2608481654 creator A5015260892 @default.
• W2608481654 creator A5025429156 @default.
• W2608481654 creator A5027912927 @default.
• W2608481654 creator A5039002989 @default.
• W2608481654 creator A5040850873 @default.
• W2608481654 creator A5041036914 @default.
• W2608481654 creator A5045486522 @default.
• W2608481654 creator A5047125463 @default.
• W2608481654 creator A5051076141 @default.
• W2608481654 creator A5052496358 @default.
• W2608481654 creator A5053275832 @default.
• W2608481654 creator A5067552911 @default.
• W2608481654 creator A5071520894 @default.
• W2608481654 creator A5073655121 @default.
• W2608481654 creator A5079121392 @default.
• W2608481654 creator A5080445936 @default.
• W2608481654 creator A5081534662 @default.
• W2608481654 date "2017-04-25" @default.
• W2608481654 modified "2023-10-16" @default.
• W2608481654 title "LX2761, a Sodium/Glucose Cotransporter 1 Inhibitor Restricted to the Intestine, Improves Glycemic Control in Mice" @default.
• W2608481654 cites W1582182371 @default.
• W2608481654 cites W1927920927 @default.
• W2608481654 cites W1946307024 @default.
• W2608481654 cites W1970942296 @default.
• W2608481654 cites W1979283687 @default.
• W2608481654 cites W1986497300 @default.
• W2608481654 cites W1991580579 @default.
• W2608481654 cites W1998742561 @default.
• W2608481654 cites W2011450045 @default.
• W2608481654 cites W2027558824 @default.
• W2608481654 cites W2031246094 @default.
• W2608481654 cites W2041059386 @default.
• W2608481654 cites W2047192155 @default.
• W2608481654 cites W2051729661 @default.
• W2608481654 cites W2052764225 @default.
• W2608481654 cites W2058969403 @default.
• W2608481654 cites W2062636052 @default.
• W2608481654 cites W2063643017 @default.
• W2608481654 cites W2065925831 @default.
• W2608481654 cites W2066245509 @default.
• W2608481654 cites W2072812733 @default.
• W2608481654 cites W2078801641 @default.
• W2608481654 cites W2079260079 @default.
• W2608481654 cites W2083119809 @default.
• W2608481654 cites W2093257905 @default.
• W2608481654 cites W2100090810 @default.
• W2608481654 cites W2109728760 @default.
• W2608481654 cites W2112043952 @default.
• W2608481654 cites W2119843247 @default.
• W2608481654 cites W2133469996 @default.
• W2608481654 cites W2145781698 @default.
• W2608481654 cites W2156215703 @default.
• W2608481654 cites W2157538794 @default.
• W2608481654 cites W2160088494 @default.
• W2608481654 cites W2167914620 @default.
• W2608481654 cites W2168842536 @default.
• W2608481654 cites W2169914389 @default.
• W2608481654 cites W2170695489 @default.
• W2608481654 cites W2175616918 @default.
• W2608481654 cites W2201588835 @default.
• W2608481654 cites W2289823333 @default.
• W2608481654 cites W2338167986 @default.
• W2608481654 cites W2473748820 @default.
• W2608481654 cites W2563224755 @default.
• W2608481654 doi "https://doi.org/10.1124/jpet.117.240820" @default.
• W2608481654 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28442582" @default.
• W2608481654 hasPublicationYear "2017" @default.
• W2608481654 type Work @default.
• W2608481654 sameAs 2608481654 @default.
• W2608481654 citedByCount "24" @default.
• W2608481654 countsByYear W26084816542017 @default.
• W2608481654 countsByYear W26084816542018 @default.
• W2608481654 countsByYear W26084816542019 @default.
• W2608481654 countsByYear W26084816542020 @default.
• W2608481654 countsByYear W26084816542021 @default.
• W2608481654 countsByYear W26084816542022 @default.
• W2608481654 countsByYear W26084816542023 @default.
• W2608481654 crossrefType "journal-article" @default.
• W2608481654 hasAuthorship W2608481654A5006130632 @default.
• W2608481654 hasAuthorship W2608481654A5006568353 @default.
• W2608481654 hasAuthorship W2608481654A5015260892 @default.
• W2608481654 hasAuthorship W2608481654A5025429156 @default.
• W2608481654 hasAuthorship W2608481654A5027912927 @default.
• W2608481654 hasAuthorship W2608481654A5039002989 @default.
• W2608481654 hasAuthorship W2608481654A5040850873 @default.
• W2608481654 hasAuthorship W2608481654A5041036914 @default.
• W2608481654 hasAuthorship W2608481654A5045486522 @default.
• W2608481654 hasAuthorship W2608481654A5047125463 @default.
• W2608481654 hasAuthorship W2608481654A5051076141 @default.
• W2608481654 hasAuthorship W2608481654A5052496358 @default.
• W2608481654 hasAuthorship W2608481654A5053275832 @default.
• W2608481654 hasAuthorship W2608481654A5067552911 @default.
• W2608481654 hasAuthorship W2608481654A5071520894 @default.
• W2608481654 hasAuthorship W2608481654A5073655121 @default.

• next